These SCN1A mutations are associated with genetic epilepsies, including Dravet syndrome (DS)/severe myoclonic epilepsy in infancy (SMEI) and genetic epilepsy with febrile seizures plus (GEFS+) [95]. This evidence concerns the gene SCN1A and Dravet syndrome.